Sponsor:
Henry Ford Health System
Code:
NCT07769151
Conditions
Mortality Prediction
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
blood sample to check CXCL9 pre stem cell transplant and cell therapy
Brief summary:
Conditions
Mortality Prediction
Study ID
NCT07769151
Start date
Sep 1, 2026
Status verified date
Aug, 2026
Completion date
Dec 30, 2031
Anticipated
Primary completion date
Dec 30, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
124 participants
Anticipated
Interventions
blood sample to check CXCL9 pre stem cell transplant and cell therapy
Primary outcome measure
Central contacts
Locations
Henry Ford Health
Recruiting
Detroit, Michigan, United States, 48202
Contacts
Sponsor
Henry Ford Health System
Last update posted
Aug 17, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Henry Ford Health System on 2026-08-17.